摘要
Objective: To evaluate the survival benefit of combining primary tumor resection (PTR) and chemotherapy in patients with unresectable colorectal mucinous adenocarcinoma with liver metastasis (UCR-MAC-LM).Methods: We obtained data from the surveillance, epidemiology, and end results database for patients with UCR-MAC-LM from 2010 to 2017. Clinicopathological characteristics were analyzed using the chi(2) test. Propensity score matching was performed to balance baseline characteristics. Kaplan-Meier analysis and log-rank tests were used to estimate and compare survival outcomes. Univariate and multivariate Cox regression analyses were conducted to identify the prognostic factors.Results: A total of 10,178 patients with unresectable colorectal adenocarcinoma with liver metastasis were included, of whom 6.01% (n=612) had UCR-MAC-LM. The UCR-MAC-LM group had a higher proportion of female patients, a greater number of elderly patients, an increased incidence of right colon localization, larger tumor size, and higher T and N staging than the unresectable colorectal non-mucinous adenocarcinoma with liver metastasis group (P<0.05). Multivariate analysis identified several independent prognostic factors (P<0.05). Patients with unresectable colorectal adenocarcinoma with liver metastasis who underwent PTR+C had superior survival rates compared with those who received PTR/C alone or no treatment (cancer-specific survival, P<0.05; overall survival, P<0.05). Subgroup analysis revealed that 17 of 22 groups of patients with UCR-MAC-LM who received PTR+C had significantly prolonged long-term survival compared with those who received PTR/C alone.Conclusions: This surveillance, epidemiology, and end results-based study indicates that PTR+C may offer a survival advantage for a specific subgroup of patients with UCR-MAC-LM compared with PTR/C alone. Nonetheless, additional clinical trials are necessary to validate these findings.
学科与关键词
- Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysisChen, Xianzhe; Hu, Weixian; Huang, Chengzhi; Liang, Weijun; Zhang, Jie; Wu, Deqing; Lv, Zejian; Li, Yong; Luo, Yuwen; Liang, Zongyu; Wang, Minjia; Wang, Junjiang; Yao, Xueqing*International Journal of Surgery, 2020, 80: 135-152.被引 10
- The role of upfront primary tumor resection in asymptomatic patients with unresectable stage IV colorectal cancer: A systematic review and meta-analysisLiang, Zongyu; Liu, Zhiyuan; Huang, Chengzhi; Chen, Xin; Zhang, Zhaojun; Xiang, Meijuan; Hu, Weixian; Wang, Junjiang; Feng, Xingyu*; Yao, Xueqing*Frontiers in Surgery, 2023, 9: 1047373.被引 2
- The tumor characteristics, treatment strategy, and prognosis in colorectal cancer patients with synchronous liver metastasis in China and the USAJiao, Shuai; Guan, Xu*; Niu, Haitao; Ma, Xiaolong; Wang, Kaifeng; Liu, Enrui; Zhang, Weiyuan; Wei, Ran; Sun, Peng; Chen, Yinggang*; Wang, Xishan*INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2023, 38(1): 140.
